← Leaderboards
John Mirsalis
Sri International
$5,655,148
Attributed
$5,655,148
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2019–23$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,655,148 · 1
By mechanism
N01$5,655,148 · 1
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Jon Carl Mirsalis$108,012,322
- Jon Mirsalis$56,020,705
- Katherine Baughman$4,521,467
- Jon Mirasilas$3,865,057
- Mary Bastida$1,457,758
Others in their field
Other Emerging Leaders on “Pathogen”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Thomas Denny · Duke University$42,477,454
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Sujatha Rashid · American Type Culture Collection$37,889,194
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
PathogenPre-ClinicalProduct DevelopmentProgramsChemistryCommunicable DiseasesInterventional Agent DevelopmentIn VitroIn VivoDevelopment PlansLeadDrug KineticsSafetyServicesSupport ContractsTherapeutic DevelopmentEvaluationToxicologyToxinMicrobiologyCytomegalovirusPoxviridaeSmallpoxAntiviral Agents
Grant awards (7)
TASK D10: EV-D68 THERAPEUTICS STUDY$211,748
N01 · FY2023 · AI · contact PI
TASK D10: NONCLINICAL SERVICES IDIQ$750,096
N01 · FY2022 · AI · contact PI
Task B15: Drug synthesis for pre-clinical in vivo and exploratory toxicology studies$52,102
N01 · FY2021 · AI · contact PI
Task B9: Synthesis of vancomycin analog precursors$295,873
N01 · FY2020 · AI · contact PI
Task B15: Synthesis of 35 g of an antiviral for pre-clinical in vivo and exploratory toxicology studies$70,604
N01 · FY2020 · AI · contact PI
Task D04: Toxicology Services$4,199,188
N01 · FY2019 · AI · contact PI
Task B7: Synthesis of a Lassa Fever antiviral$75,537
N01 · FY2019 · AI · contact PI